Titlebook: Non-invasive Prenatal Screening (NIPS) in Clinical Practice; Riyaz Ahmad Rather,Subhas Chandra Saha Book 2024 The Editor(s) (if applicable

ossicles

书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice影响因子(影响力)




书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice影响因子(影响力)学科排名




书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice网络公开度




书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice网络公开度学科排名




书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice被引频次




书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice被引频次学科排名




书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice年度引用




书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice年度引用学科排名




书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice读者反馈




书目名称Non-invasive Prenatal Screening (NIPS) in Clinical Practice读者反馈学科排名

向下

Evolution of Noninvasive Prenatal Screening: Past to Presenting issues such as chromosomal aneuploidy, X-chromosome-related disorders, monogenic disorders, in addition to gender and RhD determination. As NIPS continues to evolve, its integration into routine prenatal care becomes increasingly essential. In this chapter, our goal is to explore some milestones and trace the evolution of NIPS over time.

使害怕

Fetal Origin Circulating Cell-Free Nucleic Acids in Maternal Circulation and Their Clinical Importan NIPS now extends to disorders such as preeclampsia and gestational diabetes. Technological advancements, including polymerase chain reaction, sequencing, and microfluidics, enhance cfNAs’ use in NIPS. This chapter delves into cffNAs and their clinical applications in prenatal screening.

ONYM

Cell-Free Fetal DNA: Genesis and Clinical Utilityd cost-related concerns pose significant hurdles. Current technological advancements aim to address these challenges, holding the promise of enhancing the effectiveness and accessibility of cffDNA-based testing. This chapter explores into the existence, clinical applications, and the myriad challenges associated with cffDNA in detail.

GROUP

vocation

Noninvasive Prenatal Detection of Fetal Sex and RhD Blood TypeIts accuracy and safety make it promising for prenatal care, likely to become more prevalent. NIPS signs a transformative shift in prenatal care, improving outcomes for both mothers and unborn children.

carbohydrate

Noninvasive Prenatal Testing for Copy Number Variation and Sub-Chromosomal Variations a certain amount of risk and discomfort. Based on the analysis of cell-free placental DNA (cfpDNA) in maternal blood, NIPT offers a noninvasive alternative that has gained significant attention and acceptance in clinical practice.

轨道

Circulation Transcriptome of Maternal Plasma and Its Use in Noninvasive Prenatal Screening for early detection and diagnosis of genetic abnormalities, including chromosomal aneuploidies as well as microdeletions and microduplications. This chapter discusses various aspects of fetal transcriptome of maternal circulation in screening of fetal and maternal complications.

改变

CANON

Scope of Cell- Versus Cell-Free-Based Detection Approach in Noninvasive Prenatal Screening impacting their clinical efficacy. This chapter elucidates the role of cell-free fetal entities and cell-based entities like fetal cells in NIPS and explores their clinical significance in prenatal screening.